Cordium Pharmaceuticals Pvt Ltd is a leading oncology and specialty pharmaceutical exporter from India, supplying high-quality Rituximab Biosimilar 100mg and 500mg Injections to hospitals, distributors, government procurement agencies, oncology centers, and licensed importers worldwide.
As global demand for affordable biologic therapies continues to rise, Cordium Pharmaceuticals delivers reliable, temperature-controlled pharmaceutical export solutions to key international markets including Kenya, Nigeria, Ghana, Philippines, Vietnam, UAE, Saudi Arabia, Uzbekistan, Kazakhstan, USA, UK, and South Africa. The company highlights expertise in oncology biosimilars, cold-chain logistics, and regulatory export support.
What is Rituximab Biosimilar Injection?
Rituximab Biosimilar is a monoclonal antibody that targets the CD20 antigen found on B-cells. It is widely used in oncology and autoimmune disease management and must be administered under specialist medical supervision.
Available Strengths
Rituximab Biosimilar Injection 100mg
Rituximab Biosimilar Injection 500mg
Therapeutic Indications
Rituximab Biosimilar is prescribed for:
Non-Hodgkin's Lymphoma (NHL)
Chronic Lymphocytic Leukemia (CLL)
Rheumatoid Arthritis (RA)
Granulomatosis with Polyangiitis (GPA)
Microscopic Polyangiitis (MPA)
Other B-cell mediated disorders
Treatment should always be supervised by qualified healthcare professionals.
Why Choose Cordium Pharmaceuticals Pvt Ltd as Your Rituximab Biosimilar Export Partner?
Cordium Pharmaceuticals Pvt Ltd provides comprehensive pharmaceutical export solutions from India.
Key Advantages
✅ WHO-GMP compliant manufacturing partnerships
✅ International cold-chain shipping
✅ Export documentation support
✅ Bulk supply capabilities
✅ Competitive B2B pricing
✅ Fast global delivery
✅ Regulatory compliance assistance
✅ Reliable institutional supply chain network
Export Markets Served
🇰🇪 Kenya – Rituximab Biosimilar Supplier
Cordium Pharmaceuticals supplies Rituximab Biosimilar injections to:
Oncology hospitals
Government tenders
Cancer treatment centers
Licensed pharmaceutical importers
Private healthcare institutions
Target Cities: Nairobi, Mombasa, Kisumu, Nakuru.
🇳🇬 Nigeria – Oncology Medicine Exporter
Reliable pharmaceutical exports for:
Lagos
Abuja
Port Harcourt
Kano
Supporting oncology distributors and hospital procurement departments.
🇬🇭 Ghana – Biologic Medicine Supplier
Supplying:
Accra
Kumasi
Takoradi
Tamale
For hospitals, NGOs, and healthcare distributors.
🇵🇭 Philippines – Oncology Injection Exporter
Serving:
Manila
Quezon City
Cebu
Davao
With secure temperature-controlled shipments. The Philippines is also highlighted among Cordium's export destinations.
🇻🇳 Vietnam – Specialty Medicine Supplier
Export support for:
Ho Chi Minh City
Hanoi
Da Nang
Hai Phong
For oncology treatment programs and distributors.
🇦🇪 UAE – Trusted Oncology Exporter
Fast delivery to:
Dubai
Abu Dhabi
Sharjah
Ajman
With complete export documentation support. UAE is one of Cordium's established focus markets.
🇸🇦 Saudi Arabia – Pharmaceutical Export Solutions
Supplying:
Riyadh
Jeddah
Dammam
Mecca
For hospital procurement and licensed pharmaceutical companies.
🇺🇿 Uzbekistan – Biologics Export Partner
Serving:
Tashkent
Samarkand
Bukhara
With institutional supply programs.
🇰🇿 Kazakhstan – Oncology Medicine Supplier
Supplying:
Almaty
Astana
Shymkent
With secure international logistics.
🇺🇸 USA – Specialty Pharmaceutical Exporter
Supplying licensed buyers and institutions in:
New York
Los Angeles
Chicago
Houston
While adhering to applicable import regulations and documentation requirements.
🇬🇧 UK – Oncology Medicine Export
Serving:
London
Manchester
Birmingham
Liverpool
With compliant pharmaceutical export support.
🇿🇦 South Africa – Trusted Biologic Supplier
Supplying:
Johannesburg
Cape Town
Durban
Pretoria
South Africa is among Cordium's key international markets.
Product Specifications
Product Name Rituximab Biosimilar Injection
Available Strengths 100mg & 500mg
Dosage Form Injectable (IV Infusion)
Therapeutic Class Monoclonal Antibody
Category Oncology & Autoimmune Therapy
Packaging Cold-chain export packaging
Storage 2°C to 8°C
Country of Origin India
Export Availability Worldwide
Storage and administration must follow approved medical guidelines.
Who We Serve
Cordium Pharmaceuticals Pvt Ltd supplies:
Oncology hospitals
Cancer institutes
Government procurement agencies
Pharmaceutical distributors
Licensed pharmacies
NGOs
International healthcare organizations
Importers and wholesalers
Contact Cordium Pharmaceuticals Pvt Ltd
📍 Nagpur, Maharashtra, India
📱 WhatsApp: +91-9405117673
📧 Email: info@cordiumpharma.com
🌐 Website: www.cordiumpharma.com
Disclaimer: Rituximab Biosimilar is a prescription-only biologic medicine. International supply is subject to local import regulations, licensing requirements, and physician supervision.
As global demand for affordable biologic therapies continues to rise, Cordium Pharmaceuticals delivers reliable, temperature-controlled pharmaceutical export solutions to key international markets including Kenya, Nigeria, Ghana, Philippines, Vietnam, UAE, Saudi Arabia, Uzbekistan, Kazakhstan, USA, UK, and South Africa. The company highlights expertise in oncology biosimilars, cold-chain logistics, and regulatory export support.
What is Rituximab Biosimilar Injection?
Rituximab Biosimilar is a monoclonal antibody that targets the CD20 antigen found on B-cells. It is widely used in oncology and autoimmune disease management and must be administered under specialist medical supervision.
Available Strengths
Rituximab Biosimilar Injection 100mg
Rituximab Biosimilar Injection 500mg
Therapeutic Indications
Rituximab Biosimilar is prescribed for:
Non-Hodgkin's Lymphoma (NHL)
Chronic Lymphocytic Leukemia (CLL)
Rheumatoid Arthritis (RA)
Granulomatosis with Polyangiitis (GPA)
Microscopic Polyangiitis (MPA)
Other B-cell mediated disorders
Treatment should always be supervised by qualified healthcare professionals.
Why Choose Cordium Pharmaceuticals Pvt Ltd as Your Rituximab Biosimilar Export Partner?
Cordium Pharmaceuticals Pvt Ltd provides comprehensive pharmaceutical export solutions from India.
Key Advantages
✅ WHO-GMP compliant manufacturing partnerships
✅ International cold-chain shipping
✅ Export documentation support
✅ Bulk supply capabilities
✅ Competitive B2B pricing
✅ Fast global delivery
✅ Regulatory compliance assistance
✅ Reliable institutional supply chain network
Export Markets Served
🇰🇪 Kenya – Rituximab Biosimilar Supplier
Cordium Pharmaceuticals supplies Rituximab Biosimilar injections to:
Oncology hospitals
Government tenders
Cancer treatment centers
Licensed pharmaceutical importers
Private healthcare institutions
Target Cities: Nairobi, Mombasa, Kisumu, Nakuru.
🇳🇬 Nigeria – Oncology Medicine Exporter
Reliable pharmaceutical exports for:
Lagos
Abuja
Port Harcourt
Kano
Supporting oncology distributors and hospital procurement departments.
🇬🇭 Ghana – Biologic Medicine Supplier
Supplying:
Accra
Kumasi
Takoradi
Tamale
For hospitals, NGOs, and healthcare distributors.
🇵🇭 Philippines – Oncology Injection Exporter
Serving:
Manila
Quezon City
Cebu
Davao
With secure temperature-controlled shipments. The Philippines is also highlighted among Cordium's export destinations.
🇻🇳 Vietnam – Specialty Medicine Supplier
Export support for:
Ho Chi Minh City
Hanoi
Da Nang
Hai Phong
For oncology treatment programs and distributors.
🇦🇪 UAE – Trusted Oncology Exporter
Fast delivery to:
Dubai
Abu Dhabi
Sharjah
Ajman
With complete export documentation support. UAE is one of Cordium's established focus markets.
🇸🇦 Saudi Arabia – Pharmaceutical Export Solutions
Supplying:
Riyadh
Jeddah
Dammam
Mecca
For hospital procurement and licensed pharmaceutical companies.
🇺🇿 Uzbekistan – Biologics Export Partner
Serving:
Tashkent
Samarkand
Bukhara
With institutional supply programs.
🇰🇿 Kazakhstan – Oncology Medicine Supplier
Supplying:
Almaty
Astana
Shymkent
With secure international logistics.
🇺🇸 USA – Specialty Pharmaceutical Exporter
Supplying licensed buyers and institutions in:
New York
Los Angeles
Chicago
Houston
While adhering to applicable import regulations and documentation requirements.
🇬🇧 UK – Oncology Medicine Export
Serving:
London
Manchester
Birmingham
Liverpool
With compliant pharmaceutical export support.
🇿🇦 South Africa – Trusted Biologic Supplier
Supplying:
Johannesburg
Cape Town
Durban
Pretoria
South Africa is among Cordium's key international markets.
Product Specifications
Product Name Rituximab Biosimilar Injection
Available Strengths 100mg & 500mg
Dosage Form Injectable (IV Infusion)
Therapeutic Class Monoclonal Antibody
Category Oncology & Autoimmune Therapy
Packaging Cold-chain export packaging
Storage 2°C to 8°C
Country of Origin India
Export Availability Worldwide
Storage and administration must follow approved medical guidelines.
Who We Serve
Cordium Pharmaceuticals Pvt Ltd supplies:
Oncology hospitals
Cancer institutes
Government procurement agencies
Pharmaceutical distributors
Licensed pharmacies
NGOs
International healthcare organizations
Importers and wholesalers
Contact Cordium Pharmaceuticals Pvt Ltd
📍 Nagpur, Maharashtra, India
📱 WhatsApp: +91-9405117673
📧 Email: info@cordiumpharma.com
🌐 Website: www.cordiumpharma.com
Disclaimer: Rituximab Biosimilar is a prescription-only biologic medicine. International supply is subject to local import regulations, licensing requirements, and physician supervision.
Keywords
